Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion.

Whitt JD, Keeton AB, Gary BD, Sklar LA, Sodani K, Chen ZS, Piazza GA.

J Biomed Res. 2016 Mar;30(2):120-133. doi: 10.7555/JBR.30.20150108. Epub 2015 Nov 20.

2.

Extracellular Vesicles: Evolving Factors in Stem Cell Biology.

Nawaz M, Fatima F, Vallabhaneni KC, Penfornis P, Valadi H, Ekström K, Kholia S, Whitt JD, Fernandes JD, Pochampally R, Squire JA, Camussi G.

Stem Cells Int. 2016;2016:1073140. doi: 10.1155/2016/1073140. Epub 2015 Nov 16. Review.

3.

A Case-Control Study on the Impact of Ventilator-Associated Tracheobronchitis in the PICU.

Wheeler DS, Whitt JD, Lake M, Butcher J, Schulte M, Stalets E.

Pediatr Crit Care Med. 2015 Jul;16(6):565-71. doi: 10.1097/PCC.0000000000000405.

PMID:
25850864
4.

A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.

Whitt JD, Li N, Tinsley HN, Chen X, Zhang W, Li Y, Gary BD, Keeton AB, Xi Y, Abadi AH, Grizzle WE, Piazza GA.

Cancer Prev Res (Phila). 2012 Jun;5(6):822-33. doi: 10.1158/1940-6207.CAPR-11-0559. Epub 2012 May 3. Erratum in: Cancer Prev Res (Phila). 2013 Jan;6(1):70.

5.

NSAIDs: Old Drugs Reveal New Anticancer Targets.

Piazza GA, Keeton AB, Tinsley HN, Whitt JD, Gary BD, Mathew B, Singh R, Grizzle WE, Reynolds RC.

Pharmaceuticals (Basel). 2010 May 25;3(5):1652-1667. Review.

6.

A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity.

Piazza GA, Keeton AB, Tinsley HN, Gary BD, Whitt JD, Mathew B, Thaiparambil J, Coward L, Gorman G, Li Y, Sani B, Hobrath JV, Maxuitenko YY, Reynolds RC.

Cancer Prev Res (Phila). 2009 Jun;2(6):572-80. doi: 10.1158/1940-6207.CAPR-09-0001. Epub 2009 May 26.

Supplemental Content

Loading ...
Support Center